相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer
C-Y Lu et al.
BRITISH JOURNAL OF CANCER (2013)
Prognostic and Predictive Role of JWA and XRCC1 Expressions in Gastric Cancer
Shouyu Wang et al.
CLINICAL CANCER RESEARCH (2012)
PML as a potential predictive factor of oxaliplatin/fluoropyrimidine-based first line chemotherapy efficacy in colorectal cancer patients
Bruno Vincenzi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Genetic Polymorphism of XRCC1 Correlated with Response to Oxaliplatin-Based Chemotherapy in Advanced Colorectal Cancer
Hongying Lv et al.
PATHOLOGY & ONCOLOGY RESEARCH (2012)
Gene expression signature and response to the use of leucovorin, fluorouracil and oxaliplatin in colorectal cancer patients
Toshiaki Watanabe et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2011)
High XRCC1 Protein Expression Is Associated with Poorer Survival in Patients with Head and Neck Squamous Cell Carcinoma
Mei-Kim Ang et al.
CLINICAL CANCER RESEARCH (2011)
Multiple genetic polymorphisms in the prediction of clinical outcome of metastatic colorectal cancer patients treated with first-line FOLFOX-4 chemotherapy
Ming-Yii Huang et al.
PHARMACOGENETICS AND GENOMICS (2011)
Biodegradable Chitosan-Based Ambroxol Hydrochloride Microspheres: Effect of Cross-Linking Agents
H. H. Gangurde et al.
JOURNAL OF YOUNG PHARMACISTS (2011)
EGF61A>G polymorphism as predictive marker of clinical outcome to first-line capecitabine and oxaliplatin in metastatic colorectal cancer
K. -L. G. Spindler et al.
ANNALS OF ONCOLOGY (2010)
Socioeconomic position and participation in colorectal cancer screening
B. L. Frederiksen et al.
BRITISH JOURNAL OF CANCER (2010)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Pharmacogenetic Predictors of Adverse Events and Response to Chemotherapy in Metastatic Colorectal Cancer: Results From North American Gastrointestinal Intergroup Trial N9741
Howard L. McLeod et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prognostic Value of ERCC1, Thymidylate Synthase, and Glutathione S-Transferase π for 5-FU/Oxaliplatin Chemotherapy in Advanced Colorectal Cancer
Sung-Hyun Kim et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2009)
Very low prevalence of XPD K751Q polymorphism and its association with XPD expression and outcomes of FOLFOX-4 treatment in Asian patients with colorectal carcinoma
Jiun-I Lai et al.
CANCER SCIENCE (2009)
PERSISTENT HIGH POSTOPERATIVE CARCINOEMBRYONIC ANTIGEN IN COLORECTAL CANCER PATIENTS-IS IT IMPORTANT?
Ali Ilker Filiz et al.
CLINICS (2009)
ERCC2 2251A>C genetic polymorphism was highly correlated with early relapse in high-risk stage II and stage III colorectal cancer patients:: A preliminary study
Ming-Yii Huang et al.
BMC CANCER (2008)
Current status of excision repair cross complementing-group 1 (ERCC1) in cancer
Lucy Gossage et al.
CANCER TREATMENT REVIEWS (2007)
Systemic therapy for metastatic colorectal cancer: Current options, current evidence
H Kelly et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
ABCC5, ERCC2, XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell lines
David A. Weaver et al.
MOLECULAR CANCER (2005)
Small interfering RNA-induced suppression of ERM enhances sensitivity of human cancer cells to cisplatin
IY Chang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Quantitative real-time RT-PCR for detection of disseminated tumor cells in peripheral blood of patients with colorectal cancer using different mRNA markers
R Schuster et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
The base excision repair: mechanisms and its relevance for cancer susceptibility
P Fortini et al.
BIOCHIMIE (2003)
Mechanisms Controlling Sensitivity to Platinum Complexes: Role of p53 and DNA Mismatch Repair
S. Manic et al.
CURRENT CANCER DRUG TARGETS (2003)
The preoperative assessment and postoperative surveillance of patients with colon and rectal cancer
WE Longo et al.
SURGICAL CLINICS OF NORTH AMERICA (2002)
Increased nucleotide excision repair in cisplatin-resistant ovarian cancer cells - Role of ERCC1-XPF
KV Ferry et al.
BIOCHEMICAL PHARMACOLOGY (2000)
分享论文
